RCN3は,GRP78-PI3K-AKTシグナル伝達経路を調節することによって,結腸直腸がんにおける腫瘍プロモーターとして機能する
Mei Huang1,2, Bingru Qin1, Zhefan Xie3
1Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Oncogene
|August 23, 2025
まとめ
レチキュロカルビン3 (RCN3) は結腸直腸がん (CRC) で上位調節され,腫瘍の成長と転移を促進します. RCN3をターゲットにすることで,CRC患者の治療結果を改善するための新しい治療戦略を提供することができる.
科学分野:
- 腫瘍学
- 分子生物学
- 細胞生物学
背景:
- 結腸直腸がんは 世界的に深刻な健康問題となっています
- CRCでは新しい治療目標と予後バイオマーカーが不可欠です.
- レチキュロカルビン-3 (RCN3) は,がんの進行に関連する細胞プロセスに関与しています.
研究 の 目的:
- 結腸直腸がん (CRC) の発症におけるレチキュロカルビン3 (RCN3) の役割を調査する.
- CRCにおけるカルシウムホメオスタシスと輸送タンパク質に対するRCN3の規制効果を調査する.
- CRCの潜在的予後バイオマーカーおよび治療標的としてRCN3を評価する.
主な方法:
- バイオインフォマティック分析
- 定量的リアルタイムPCR (qRT-PCR)
- ウエスタン・ブロッティング
- 免疫ヒストケミストリー
- インビトロおよびインビボ機能検査
主要な成果:
- RCN3の発現はCRC組織で上位調節され,不良な患者の結果と相関しています.
- 変化したRCN3発現は,CRC細胞の増殖,移動,侵入を著しく促進する.
- RCN3はGRP78と相互作用し,カルシウムレベル,内プラズマ網膜ストレス,PI3K- AKT- mTOR- S6経路に影響する.
結論:
- RCN3は,CRCの進行を促進する多面的な役割を果たします.
- RCN3は,CRCの潜在的な予後バイオマーカーです.
- RCN3は結腸直腸がんの治療において有望な標的となる.
関連する概念動画
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K


